doxorubicin

North America

Canada (9)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAELYX 2MG/ML susp
Rx
iv
L01DB01
DOXORUBICIN 2MG/ML sol
Rx
iv/intravesical
L01DB01
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 10MG/VIAL powd for sol
Rx
iv/intravesical
L01DB01
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 150MG/VIAL powd for sol
Rx
iv/intravesical
L01DB01
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 50MG/VIAL powd for sol
Rx
iv/intravesical
L01DB01
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG/ML sol
Rx
iv/intravesical
L01DB01
DOXORUBICIN HYDROCHLORIDE INJECTION; USP 2MG/ML sol
Rx
iv/intravesical
L01DB01
DOXORUBICIN INJECTION; BP 2MG/ML sol
Rx
iv/intravesical
L01DB01
TARO-DOXORUBICIN LIPOSOMAL 2MG/ML susp
Rx
iv
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAELYX 2MG/ML susp
02238389
DOXORUBICIN 2MG/ML sol
02410397
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 10MG/VIAL powd for sol
02194457
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 150MG/VIAL powd for sol
02194473
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP 50MG/VIAL powd for sol
02194465
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG/ML sol
02409275
DOXORUBICIN HYDROCHLORIDE INJECTION; USP 2MG/ML sol
02413973
DOXORUBICIN INJECTION; BP 2MG/ML sol
02381982
TARO-DOXORUBICIN LIPOSOMAL 2MG/ML susp
02493020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (46)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIAMYCIN PFS 200MG/100ML inj
N
INJECTION
L01DB01
ADRIAMYCIN PFS 2MG/ML inj
N
INJECTION
L01DB01
DOXIL (LIPOSOMAL) 20MG/10ML (2MG/ML) INJECTABLE, LIPOSOMAL
Y
Rx
INJECTION
L01DB01
DOXIL (LIPOSOMAL) 50MG/25ML (2MG/ML) INJECTABLE, LIPOSOMAL
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 20MG/10ML (2MG/ML) INJECTABLE, LIPOSOMAL
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 20MG/10ML (2MG/ML) INJECTABLE, LIPOSOMAL
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 50MG/25ML (2MG/ML) INJECTABLE, LIPOSOMAL
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 50MG/25ML (2MG/ML) INJECTABLE, LIPOSOMAL
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 10MG/VIAL inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 10MG/VIAL inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 10MG/VIAL inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 10MG/VIAL inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 150MG/75ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 150MG/VIAL inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 20MG/10ML (2MG/ML) INJECTABLE, LIPOSOMAL
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 50MG/25ML (2MG/ML) INJECTABLE, LIPOSOMAL
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
N
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
Y
Rx
INJECTION
L01DB01
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
Y
Rx
INJECTION
L01DB01
RUBEX 100MG/VIAL inj
N
INJECTION
L01DB01
RUBEX 10MG/VIAL inj
N
INJECTION
L01DB01
RUBEX 50MG/VIAL inj
N
INJECTION
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIAMYCIN PFS 200MG/100ML inj
63165/2
ANDA
30-01-1991
ADRIAMYCIN PFS 2MG/ML inj
63165/1
ANDA
30-01-1991
DOXIL (LIPOSOMAL) 20MG/10ML (2MG/ML) INJECTABLE, LIPOSOMAL
50718/1
NDA
17-11-1995
DOXIL (LIPOSOMAL) 50MG/25ML (2MG/ML) INJECTABLE, LIPOSOMAL
50718/2
NDA
13-06-2000
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 20MG/10ML (2MG/ML) INJECTABLE, LIPOSOMAL
208657/1
ANDA
15-05-2017
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 20MG/10ML (2MG/ML) INJECTABLE, LIPOSOMAL
203263/1
ANDA
04-02-2013
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 50MG/25ML (2MG/ML) INJECTABLE, LIPOSOMAL
208657/2
ANDA
15-05-2017
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 50MG/25ML (2MG/ML) INJECTABLE, LIPOSOMAL
203263/2
ANDA
04-02-2013
DOXORUBICIN HYDROCHLORIDE 10MG/VIAL inj
200170/1
ANDA
28-10-2011
DOXORUBICIN HYDROCHLORIDE 10MG/VIAL inj
50467/1
NDA
01-01-1982
DOXORUBICIN HYDROCHLORIDE 10MG/VIAL inj
63097/1
ANDA
21-05-1990
DOXORUBICIN HYDROCHLORIDE 10MG/VIAL inj
62921/1
ANDA
17-03-1989
DOXORUBICIN HYDROCHLORIDE 150MG/75ML inj
50629/3
NDA
28-03-2011
DOXORUBICIN HYDROCHLORIDE 150MG/VIAL inj
50467/4
NDA
22-07-1987
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
203622/2
ANDA
27-06-2014
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
50629/2
NDA
03-05-1988
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
63336/4
ANDA
28-02-1995
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
64140/2
ANDA
28-07-1995
DOXORUBICIN HYDROCHLORIDE 200MG/100ML inj
64097/1
ANDA
13-09-1994
DOXORUBICIN HYDROCHLORIDE 20MG/10ML (2MG/ML) INJECTABLE, LIPOSOMAL
212299/1
ANDA
10-09-2020
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
208888/1
ANDA
17-02-2017
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
206062/1
ANDA
13-05-2019
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
50467/3
NDA
20-05-1985
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
63097/2
ANDA
21-05-1990
DOXORUBICIN HYDROCHLORIDE 20MG/VIAL inj
62921/2
ANDA
17-03-1989
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
203622/1
ANDA
27-06-2014
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
65515/1
ANDA
08-11-2012
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
63277/1
ANDA
26-10-1995
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
209825/1
ANDA
11-08-2017
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
200146/1
ANDA
18-07-2012
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
200901/1
ANDA
14-02-2012
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
50629/1
NDA
23-12-1987
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
63336/1
ANDA
28-02-1995
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
91495/1
ANDA
18-03-2013
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
91418/1
ANDA
15-02-2012
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
64140/1
ANDA
28-07-1995
DOXORUBICIN HYDROCHLORIDE 2MG/ML inj
62975/1
ANDA
17-03-1989
DOXORUBICIN HYDROCHLORIDE 50MG/25ML (2MG/ML) INJECTABLE, LIPOSOMAL
212299/2
ANDA
10-09-2020
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
208888/2
ANDA
17-02-2017
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
200170/2
ANDA
28-10-2011
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
50467/2
NDA
01-01-1982
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
63097/3
ANDA
21-05-1990
DOXORUBICIN HYDROCHLORIDE 50MG/VIAL inj
62921/3
ANDA
17-03-1989
RUBEX 100MG/VIAL inj
62926/3
ANDA
13-04-1989
RUBEX 10MG/VIAL inj
62926/1
ANDA
13-04-1989
RUBEX 50MG/VIAL inj
62926/2
ANDA
13-04-1989
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIBLASTIN 50 MG TROCKENSTECHAMPULLE -
Rx
-
L01DB01
ADRIBLASTIN 10 MG STECHAMPULLE -
Rx
-
L01DB01
ADRIBLASTIN 200 MG STECHAMPULLE -
Rx
-
L01DB01
ADRIBLASTIN 50 MG STECHAMPULLE -
Rx
-
L01DB01
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN EBEWE 2 MG/ML - STECHAMPULLE -
Rx
-
L01DB01
MYOCET 50 MG powd, disp & solv for conc for disp for inf
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIBLASTIN 50 MG TROCKENSTECHAMPULLE -
16751
19-06-1980
ADRIBLASTIN 10 MG STECHAMPULLE -
1-20169
28-09-1993
ADRIBLASTIN 200 MG STECHAMPULLE -
1-20166
28-09-1993
ADRIBLASTIN 50 MG STECHAMPULLE -
1-20167
28-09-1993
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
1-29692
22-09-2010
DOXORUBICIN EBEWE 2 MG/ML - STECHAMPULLE -
1-21284
21-03-1996
MYOCET 50 MG powd, disp & solv for conc for disp for inf
EU/1/00/141/001
13-07-2000
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (14)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIBLASTINA 10 10 MG powd for sol for inj
10 mg
10 mg
Y
Y

iv/intraarterial
L01DB01
ADRIBLASTINA 10 READY TO USE 10 MG sol for inj
5 mL
Y
iv/intravesical
L01DB01
ADRIBLASTINA 150 150 MG powd for sol for inj
150 mg
-
iv
L01DB01
ADRIBLASTINA 20 READY TO USE 20 MG sol for inj
10 mL
-
iv
L01DB01
ADRIBLASTINA 200 READY TO USE 200 MG sol for inj
100 mL
Y
iv/intravesical
L01DB01
ADRIBLASTINA 50 50 MG powd for sol for inj
50 mg
-
iv/intraarterial
L01DB01
ADRIBLASTINA 50 READY TO USE 50 MG sol for inj
25 mL
Y
iv/intravesical
L01DB01
DOXORUBICIN AB 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
50 mL
75 mL
-
-
-
-
-
-





iv
L01DB01
DOXORUBICIN ACCORD HEALTHCARE 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
50 mL
-
Y
Y
Y
Y




iv/intravesical
L01DB01
DOXORUBICINE MYLAN 2 MG/ML powd for conc for sol for inf
10 mg
50 mg
-
-

iv
L01DB01
DOXORUBICINE MYLAN 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
-
-
-
-



iv
L01DB01
DOXORUBICINE SANDOZ 2 MG/ML conc for sol for inf
100 mL
25 mL
5 mL
5 mL
50 mL
-
-
-
Y
-




iv/intravesical
L01DB01
DOXORUBICINE TEVA 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
-
Y
Y
Y



iv
L01DB01
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
1,9 mL, 3 mL, 50 mg
3 mL, 50 mg
Y
-

iv
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIBLASTINA 10 10 MG powd for sol for inj
10 mg
10 mg
BE063357
BE063357
-
-
ADRIBLASTINA 10 READY TO USE 10 MG sol for inj
5 mL
BE146571
-
ADRIBLASTINA 150 150 MG powd for sol for inj
150 mg
BE146605
-
ADRIBLASTINA 20 READY TO USE 20 MG sol for inj
10 mL
BE146587
-
ADRIBLASTINA 200 READY TO USE 200 MG sol for inj
100 mL
BE146562
-
ADRIBLASTINA 50 50 MG powd for sol for inj
50 mg
BE110756
-
ADRIBLASTINA 50 READY TO USE 50 MG sol for inj
25 mL
BE146596
-
DOXORUBICIN AB 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
50 mL
75 mL
BE408152
BE408195
BE408161
BE408143
BE408177
BE408186
-
-
-
-
-
-
DOXORUBICIN ACCORD HEALTHCARE 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
50 mL
BE443843
BE398343
BE398334
BE398325
BE452293
-
-
-
-
-
DOXORUBICINE MYLAN 2 MG/ML powd for conc for sol for inf
10 mg
50 mg
BE467164
BE467173
-
-
DOXORUBICINE MYLAN 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
BE467137
BE467155
BE467146
BE467120
-
-
-
-
DOXORUBICINE SANDOZ 2 MG/ML conc for sol for inf
100 mL
25 mL
5 mL
5 mL
50 mL
BE291374
BE291356
BE291347
BE291347
BE291365
-
-
-
-
-
DOXORUBICINE TEVA 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
BE353841
BE353866
BE353857
BE353832
-
-
-
-
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
1,9 mL, 3 mL, 50 mg
3 mL, 50 mg
EU/1/00/141/001
EU/1/00/141/002
CP
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
ADRIBLASTINA 10 10 MG powd for sol for inj
10 mg
10 mg
ADRIBLASTINA 10 READY TO USE 10 MG sol for inj
5 mL
6,15
ADRIBLASTINA 150 150 MG powd for sol for inj
150 mg
ADRIBLASTINA 20 READY TO USE 20 MG sol for inj
10 mL
ADRIBLASTINA 200 READY TO USE 200 MG sol for inj
100 mL
97,93
ADRIBLASTINA 50 50 MG powd for sol for inj
50 mg
ADRIBLASTINA 50 READY TO USE 50 MG sol for inj
25 mL
27,38
DOXORUBICIN AB 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
50 mL
75 mL
DOXORUBICIN ACCORD HEALTHCARE 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
50 mL
97,93
27,38
6,15
54,75
DOXORUBICINE MYLAN 2 MG/ML powd for conc for sol for inf
10 mg
50 mg
DOXORUBICINE MYLAN 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
DOXORUBICINE SANDOZ 2 MG/ML conc for sol for inf
100 mL
25 mL
5 mL
5 mL
50 mL
DOXORUBICINE TEVA 2 MG/ML conc for sol for inf
10 mL
100 mL
25 mL
5 mL
97,93
27,38
6,15
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
1,9 mL, 3 mL, 50 mg
3 mL, 50 mg
881,16
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
DOXORUBICIN EBEWE 2 MG/ML conc for sol for inf
1 bottle sa 25 mL koncentrata za sol for
1 bottle sa 5 mL koncentrata za sol for
Rx
Rx
-
L01DB01
DOXORUBICIN PLIVA 2 MG/ ML 2 MG/ML sol for inj
1 glass bottle sa 25 ml otopine za injek
1 glass bottle sa 5 ml otopine za injekc
Rx
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
DOXORUBICIN EBEWE 2 MG/ML conc for sol for inf
1 bottle sa 25 mL koncentrata za sol for
1 bottle sa 5 mL koncentrata za sol for
BIH-H-0789492-4
BIH-H-8779727-3
-
-
08-07-2020
08-07-2020
07-07-2025
07-07-2025
DOXORUBICIN PLIVA 2 MG/ ML 2 MG/ML sol for inj
1 glass bottle sa 25 ml otopine za injek
1 glass bottle sa 5 ml otopine za injekc
BIH-H-4918302-8
BIH-H-0629897-2
-
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Croatia (4)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
DOXORUBICIN PLIVA 2 MG/ML sol for inj/inf
1 bočica 25 ml otopina
1 bočica 5 ml otopina
Y
Y
Rx
Rx
-
L01DB01
MYOCET -
Y
Rx
-
L01DB01
SINDROXOCIN 10 MG powd for sol for inj/inf
1 bočica praškom
T
Rx
-
L01DB01
SINDROXOCIN 50 MG powd for sol for inj/inf
1 bočica praškom
T
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
DOXORUBICIN PLIVA 2 MG/ML sol for inj/inf
1 bočica 25 ml otopina
1 bočica 5 ml otopina
HR-H-144429570-02
HR-H-144429570-01
29-08-2018
29-08-2018
MYOCET -
SINDROXOCIN 10 MG powd for sol for inj/inf
1 bočica praškom
HR-H-738497600-01
26-11-2015
SINDROXOCIN 50 MG powd for sol for inj/inf
1 bočica praškom
HR-H-584620676-01
26-11-2015
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Czechia (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIBLASTINA CS 2MG/ML sol for inj
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X5ML
N
N
N
N
iv/intravesical/intraarterial
L01DB01
CAELYX PEGYLATED LIPOSOMAL 2MG/ML conc for sol for inf
2MG/ML 10X10ML
2MG/ML 10X25ML
2MG/ML 1X10ML
2MG/ML 1X25ML
N
N
Y
N
iv
L01DB01
DOXORUBICIN EBEWE 2MG/ML conc for sol for inf
2MG/ML 1X100ML
2MG/ML 1X25ML
2MG/ML 1X50ML
2MG/ML 1X5ML
N
Y
N
Y
iv/intravesical
L01DB01
DOXORUBICIN MEDAC 2MG/ML sol for inf
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X5ML
2MG/ML 1X75ML
2MG/ML 5X100ML
2MG/ML 5X10ML
2MG/ML 5X25ML
2MG/ML 5X5ML
2MG/ML 5X75ML
Y
N
Y
N
N
N
N
N
N
N
iv/intravesical
L01DB01
DOXORUBICIN PHARMAGEN 2MG/ML conc for sol for inf
2MG/ML 10X10ML
2MG/ML 10X5ML
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X50ML
2MG/ML 1X5ML
2MG/ML 1X75ML
N
N
N
N
Y
Y
Y
N
iv/intravesical/intraarterial
L01DB01
DOXORUBICIN TEVA 2MG/ML conc for sol for inf
2MG/ML 100ML
2MG/ML 10ML
2MG/ML 25ML
2MG/ML 5ML
Y
N
Y
Y
iv/intravesical
L01DB01
MYOCET LIPOSOMAL 50MG powd, disp & solv for conc for disp for inf
50MG 1XSET
50MG 2XSET
N
Y
iv
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIBLASTINA CS 2MG/ML sol for inj
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X5ML
44/ 369/00-C
44/ 369/00-C
44/ 369/00-C
44/ 369/00-C
NP
NP
NP
NP
CAELYX PEGYLATED LIPOSOMAL 2MG/ML conc for sol for inf
2MG/ML 10X10ML
2MG/ML 10X25ML
2MG/ML 1X10ML
2MG/ML 1X25ML
EU/1/96/011/002
EU/1/96/011/004
EU/1/96/011/001
EU/1/96/011/003
CP
CP
CP
CP
DOXORUBICIN EBEWE 2MG/ML conc for sol for inf
2MG/ML 1X100ML
2MG/ML 1X25ML
2MG/ML 1X50ML
2MG/ML 1X5ML
44/ 577/97-C
44/ 577/97-C
44/ 577/97-C
44/ 577/97-C
NP
NP
NP
NP
DOXORUBICIN MEDAC 2MG/ML sol for inf
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X5ML
2MG/ML 1X75ML
2MG/ML 5X100ML
2MG/ML 5X10ML
2MG/ML 5X25ML
2MG/ML 5X5ML
2MG/ML 5X75ML
44/ 254/10-C
44/ 254/10-C
44/ 254/10-C
44/ 254/10-C
44/ 254/10-C
44/ 254/10-C
44/ 254/10-C
44/ 254/10-C
44/ 254/10-C
44/ 254/10-C
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
DOXORUBICIN PHARMAGEN 2MG/ML conc for sol for inf
2MG/ML 10X10ML
2MG/ML 10X5ML
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X50ML
2MG/ML 1X5ML
2MG/ML 1X75ML
44/ 315/15-C
44/ 315/15-C
44/ 315/15-C
44/ 315/15-C
44/ 315/15-C
44/ 315/15-C
44/ 315/15-C
44/ 315/15-C
NP
NP
NP
NP
NP
NP
NP
NP
DOXORUBICIN TEVA 2MG/ML conc for sol for inf
2MG/ML 100ML
2MG/ML 10ML
2MG/ML 25ML
2MG/ML 5ML
44/ 850/09-C
44/ 850/09-C
44/ 850/09-C
44/ 850/09-C
MRP/DCP
MRP/DCP
MRP/DCP
MRP/DCP
MYOCET LIPOSOMAL 50MG powd, disp & solv for conc for disp for inf
50MG 1XSET
50MG 2XSET
EU/1/00/141/002
EU/1/00/141/001
CP
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
ADRIBLASTINA CS 2MG/ML sol for inj
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X5ML
0
0
565,61
138,11
804,91
208,13
CAELYX PEGYLATED LIPOSOMAL 2MG/ML conc for sol for inf
2MG/ML 10X10ML
2MG/ML 10X25ML
2MG/ML 1X10ML
2MG/ML 1X25ML
0
0
17033,63
0
20055,53
DOXORUBICIN EBEWE 2MG/ML conc for sol for inf
2MG/ML 1X100ML
2MG/ML 1X25ML
2MG/ML 1X50ML
2MG/ML 1X5ML
0
471,34
0
138
679,21
207,97
DOXORUBICIN MEDAC 2MG/ML sol for inf
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X5ML
2MG/ML 1X75ML
2MG/ML 5X100ML
2MG/ML 5X10ML
2MG/ML 5X25ML
2MG/ML 5X5ML
2MG/ML 5X75ML
570,36
0
668,55
0
0
0
0
0
0
0
811,18
940,79
DOXORUBICIN PHARMAGEN 2MG/ML conc for sol for inf
2MG/ML 10X10ML
2MG/ML 10X5ML
2MG/ML 1X100ML
2MG/ML 1X10ML
2MG/ML 1X25ML
2MG/ML 1X50ML
2MG/ML 1X5ML
2MG/ML 1X75ML
0
0
0
0
668,55
997,75
98,28
0
940,79
1375,33
148,11
DOXORUBICIN TEVA 2MG/ML conc for sol for inf
2MG/ML 100ML
2MG/ML 10ML
2MG/ML 25ML
2MG/ML 5ML
1983,24
0
487,03
144,22
2643,73
700,61
217,34
MYOCET LIPOSOMAL 50MG powd, disp & solv for conc for disp for inf
50MG 1XSET
50MG 2XSET
0
23545,7
27362,08
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (12)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIAMYCIN 10 MG powd for sol for inj
-
-
L01DB01
ADRIAMYCIN 150 MG powd for sol for inj
-
-
L01DB01
ADRIAMYCIN 2 MG/ML sol for inj
-
-
L01DB01
ADRIAMYCIN 20 MG powd for sol for inj
-
-
L01DB01
ADRIAMYCIN 50 MG powd for sol for inj
-
-
L01DB01
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
-
-
L01DB01
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
-
-
L01DB01
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
-
-
L01DB01
DOXORUBICIN EBEWE 2 MG/ML sol for inj
-
-
L01DB01
DOXORUBICIN GENEPHARM 2 MG/ML sol for inj
-
-
L01DB01
DOXORUBICIN TEVA 2 MG/ML conc for sol for inf
-
-
L01DB01
MYOCET 50 MG powd for conc for sol for inf
-
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIAMYCIN 10 MG powd for sol for inj
28100920277
NP
24-10-1979
ADRIAMYCIN 150 MG powd for sol for inj
28101310487
NP
15-04-1993
ADRIAMYCIN 2 MG/ML sol for inj
28101313487
NP
12-10-1988
ADRIAMYCIN 20 MG powd for sol for inj
28101258686
NP
07-11-1986
ADRIAMYCIN 50 MG powd for sol for inj
28100920177
NP
24-10-1979
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
28101716794
CP
21-06-1996
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
28104407708
DCP
18-05-2010
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
28104822810
DCP
20-12-2011
DOXORUBICIN EBEWE 2 MG/ML sol for inj
28103012898
NP
11-08-1999
DOXORUBICIN GENEPHARM 2 MG/ML sol for inj
28103733704
NP
26-03-2008
DOXORUBICIN TEVA 2 MG/ML conc for sol for inf
28104350308
DCP
03-11-2009
MYOCET 50 MG powd for conc for sol for inf
28103034198
CP
13-07-2000
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
ADRIAMYCIN 10 MG powd for sol for inj
ADRIAMYCIN 150 MG powd for sol for inj
ADRIAMYCIN 2 MG/ML sol for inj
ADRIAMYCIN 20 MG powd for sol for inj
ADRIAMYCIN 50 MG powd for sol for inj
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
DOXORUBICIN EBEWE 2 MG/ML sol for inj
DOXORUBICIN GENEPHARM 2 MG/ML sol for inj
DOXORUBICIN TEVA 2 MG/ML conc for sol for inf
MYOCET 50 MG powd for conc for sol for inf
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (6)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
10 ml in vial
10 x 10 ml in vial
10 x 25 ml in vial
25 ml in vial
Y
N
N
N
Rx
Rx
Rx
Rx
-
L01DB01
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
10 ml in vial
N
Rx
-
L01DB01
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
10 ml in vial
100 ml in vial
25 ml in vial
5 ml in vial
50 ml in vial
Y
Y
Y
Y
N
Rx
Rx
Rx
Rx
Rx
-
L01DB01
DOXORUBICIN EBEWE 2 MG/ML sol for inj
10 ml in vial
100 ml in vial
25 ml in vial
5 ml in vial
5 x 10 ml in vial
N
N
N
N
N
Rx
Rx
Rx
Rx
Rx
-
L01DB01
DOXORUBICIN MEDAC 2 MG/ML sol for inf
10 ml in vial
100 ml in vial
25 ml in vial
5 ml in vial
5 x 10 ml in vial
5 x 100 ml in vial
5 x 25 ml in vial
5 x 5 ml in vial
5 x 75 ml in vial
75 ml in vial
N
Y
Y
N
N
N
N
N
N
N
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
L01DB01
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
2 x 50 mg in vial
50 mg in vial
N
N
Rx
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
10 ml in vial
10 x 10 ml in vial
10 x 25 ml in vial
25 ml in vial
-
-
-
-
21-06-1996
21-06-1996
21-06-1996
21-06-1996
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
10 ml in vial
PI
21-05-2019
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
10 ml in vial
100 ml in vial
25 ml in vial
5 ml in vial
50 ml in vial
25588
25588
25588
25588
25588
-
-
-
-
-
31-05-2011
31-05-2011
31-05-2011
31-05-2011
31-05-2011
DOXORUBICIN EBEWE 2 MG/ML sol for inj
10 ml in vial
100 ml in vial
25 ml in vial
5 ml in vial
5 x 10 ml in vial
13644
13644
13644
13644
13644
-
-
-
-
-
18-01-1999
18-01-1999
18-01-1999
18-01-1999
18-01-1999
DOXORUBICIN MEDAC 2 MG/ML sol for inf
10 ml in vial
100 ml in vial
25 ml in vial
5 ml in vial
5 x 10 ml in vial
5 x 100 ml in vial
5 x 25 ml in vial
5 x 5 ml in vial
5 x 75 ml in vial
75 ml in vial
27897
27897
27897
27897
27897
27897
27897
27897
27897
27897
-
-
-
-
-
-
-
-
-
-
28-04-2011
28-04-2011
28-04-2011
28-04-2011
28-04-2011
28-04-2011
28-04-2011
28-04-2011
28-04-2011
28-04-2011
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
2 x 50 mg in vial
50 mg in vial
-
-
13-07-2000
13-07-2000
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Hungary (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAELYX 2 MG/ML conc for sol for inf
10x10 ml vial
10x25 ml vial
1x10 ml vial
1x25 ml vial
N
N
Y
N
Rx
Rx
Rx
Rx
parenteral
L01DB01
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
1x100ml vial
1x10ml vial
1x25ml vial
1x50ml vial
1x5ml vial
N
N
N
N
N
Rx
Rx
Rx
Rx
Rx
parenteral
L01DB01
DOXORUBICIN SANDOZ 2 MG/ML conc for sol for inf
1x25ml vial
1x5ml vial
Y
N
Rx
Rx
parenteral
L01DB01
DOXORUBICIN-TEVA 2 MG/ML sol for inj
10x10 mg/5ml glass 6 ml
10x10 mg/5ml glass iso 6r
1x10 mg/5ml glass 6 ml
1x10 mg/5ml glass iso 6r
1x20 mg/10ml vial
1x200 mg/100ml glass 100 ml
1x200 mg/100ml glass iso 100r
1x50 mg/25ml vial
N
N
N
N
N
N
N
Y
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
-
L01DB01
MYOCET LIPOSOMAL 50 MG , DISZPERZIÓ ÉS DISZPERZIÓS KÉSZÍTÉ solv for …
1x készlet 1 készlet 3 inj glassből (1 p
2x készlet 1 készlet 3 inj glassből (1 p
N
Y
Rx
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAELYX 2 MG/ML conc for sol for inf
10x10 ml vial
10x25 ml vial
1x10 ml vial
1x25 ml vial
EU/1/96/011/002
EU/1/96/011/004
EU/1/96/011/001
EU/1/96/011/003
21-06-1996
21-06-1996
21-06-1996
21-06-1996
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
1x100ml vial
1x10ml vial
1x25ml vial
1x50ml vial
1x5ml vial
OGYI-T-21409/03
OGYI-T-21409/04
OGYI-T-21409/02
OGYI-T-21409/05
OGYI-T-21409/01
24-08-2010
24-08-2010
24-08-2010
24-08-2010
24-08-2010
DOXORUBICIN SANDOZ 2 MG/ML conc for sol for inf
1x25ml vial
1x5ml vial
OGYI-T-06988/02
OGYI-T-06988/01
22-07-1999
22-07-1999
DOXORUBICIN-TEVA 2 MG/ML sol for inj
10x10 mg/5ml glass 6 ml
10x10 mg/5ml glass iso 6r
1x10 mg/5ml glass 6 ml
1x10 mg/5ml glass iso 6r
1x20 mg/10ml vial
1x200 mg/100ml glass 100 ml
1x200 mg/100ml glass iso 100r
1x50 mg/25ml vial
OGYI-T-08808/07
OGYI-T-08808/02
OGYI-T-08808/06
OGYI-T-08808/01
OGYI-T-08808/03
OGYI-T-08808/05
OGYI-T-08808/08
OGYI-T-08808/04
04-03-2003
04-03-2003
04-03-2003
04-03-2003
04-03-2003
04-03-2003
04-03-2003
04-03-2003
MYOCET LIPOSOMAL 50 MG , DISZPERZIÓ ÉS DISZPERZIÓS KÉSZÍTÉ solv for …
1x készlet 1 készlet 3 inj glassből (1 p
2x készlet 1 készlet 3 inj glassből (1 p
EU/1/00/141/002
EU/1/00/141/001
13-07-2000
13-07-2000
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
CAELYX 2 MG/ML conc for sol for inf
10x10 ml vial
10x25 ml vial
1x10 ml vial
1x25 ml vial
0
0
132598
309540
0
0
138432,31
323159,76
0
0
139422
324150
0
0
146393
340358
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
1x100ml vial
1x10ml vial
1x25ml vial
1x50ml vial
1x5ml vial
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
DOXORUBICIN SANDOZ 2 MG/ML conc for sol for inf
1x25ml vial
1x5ml vial
12405
2460
12950,82
2568,24
13941
3082
14638
3236
DOXORUBICIN-TEVA 2 MG/ML sol for inj
10x10 mg/5ml glass 6 ml
10x10 mg/5ml glass iso 6r
1x10 mg/5ml glass 6 ml
1x10 mg/5ml glass iso 6r
1x20 mg/10ml vial
1x200 mg/100ml glass 100 ml
1x200 mg/100ml glass iso 100r
1x50 mg/25ml vial
0
16931
0
1806
3612
36120
0
9034
0
17675,96
0
1896,3
3770,93
37709,28
0
9431,5
0
18666
0
2276
4471
38699
0
10422
0
19599
0
2390
4695
40634
0
10943
MYOCET LIPOSOMAL 50 MG , DISZPERZIÓ ÉS DISZPERZIÓS KÉSZÍTÉ solv for …
1x készlet 1 készlet 3 inj glassből (1 p
2x készlet 1 készlet 3 inj glassből (1 p
0
345464
0
360664,42
0
361654
0
379737
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Iceland (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIAMYCIN 2 MG/ML sol for inj
Y
Y
Rx
Rx
-
L01DB01
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
Y
Rx
-
L01DB01
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
N
Rx
-
L01DB01
DOXORUBICIN MEDAC 2 MG/ML sol for inf
Y
Rx
-
L01DB01
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
N
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIAMYCIN 2 MG/ML sol for inj
01-04-1990
01-04-1990
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
01-05-1999
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
29-11-2011
DOXORUBICIN MEDAC 2 MG/ML sol for inf
11-07-2017
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
31-07-2003
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
ADRIAMYCIN 2 MG/ML sol for inj
3.084
7.710
3.084
7.710
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
55.820
55.820
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
DOXORUBICIN MEDAC 2 MG/ML sol for inf
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Ireland (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAELYX 2 MG/ML conc for susp for inf
Y
Rx
iv
L01DB01
CAELYX 2.0 MG/ML conc for susp for inf
Y
Rx
iv
L01DB01
DOXORUBICIN 2 MG/ML conc for sol for inf
Y
Rx
iv/intravesical
L01DB01
DOXORUBICIN 2MG/ML 2 MG/ML conc for sol for inf
Y
Rx
iv
L01DB01
DOXORUBICIN 2MG/ML 2 MG/ML conc for sol for inf
N
Rx
iv/intravesical
L01DB01
DOXORUBICIN TEVA 2 MG/ML conc for sol for inf
Y
Rx
iv
L01DB01
MYOCET 50 BASE MGS powd & solv for conc for disp for inf
-
Rx
iv
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAELYX 2 MG/ML conc for susp for inf
EU/1/96/011/001
21-06-1996
CAELYX 2.0 MG/ML conc for susp for inf
EU/1/96/011/002
21-06-1996
DOXORUBICIN 2 MG/ML conc for sol for inf
PA2315/083/001
09-07-2010
DOXORUBICIN 2MG/ML 2 MG/ML conc for sol for inf
PA1380/111/001
09-12-2011
DOXORUBICIN 2MG/ML 2 MG/ML conc for sol for inf
PA22766/004/001
29-01-2010
DOXORUBICIN TEVA 2 MG/ML conc for sol for inf
PA0749/083/001
20-11-2009
MYOCET 50 BASE MGS powd & solv for conc for disp for inf
EU/1/00/141/001
13-07-2000
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (14)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
A.D. MYCIN 50 MG/25 ML conc for sol for inf
N1 nenurodyta
Rx
-
L01DB01
CAELYX PEGYLATED LIPOSOMAL [CAELYX] 2 MG/ML conc for sol for inf
10 ml N1 vial
10 ml N10 vial
25 ml N1 vial
25 ml N10 vial
Rx
Rx
Rx
Rx
iv
L01DB01
CAELYX PEGYLATED LIPOSOMAL [CAELYX] 2 MG/ML conc for sol for inf
10 ml N1 vial
Rx
iv
L01DB01
DOKSORUBICINA HIDROCHLORID 10 MG powd for sol for inf
N1 nenurodyta
Rx
-
L01DB01
DOKSORUBICINAS MYLAN [DOKSORUBICINAS AGILA] 2 MG/ML powd for conc for sol for inf
10 mg N1 vial
50 mg N1 vial
Rx
Rx
iv/intravesical
L01DB01
DOKSORUBICINAS MYLAN [DOKSORUBICINAS AGILA] 2 MG/ML conc for sol for inf
10 ml N1 (20 mg /10 ml) vial
100 ml N1 (200 mg/100 ml) vial
25 ml N1 (50 mg/25 ml) vial
5 ml N1 (10 mg/5 ml) vial
Rx
Rx
Rx
Rx
iv/intravesical
L01DB01
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
10 ml N1 vial
100 ml N1 vial
25 ml N1 vial
5 ml N1 vial
50 ml N1 vial
Rx
Rx
Rx
Rx
Rx
iv/intravesical
L01DB01
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
10 ml N1 vial
10 ml N10 vial
100 ml N1 vial
25 ml N1 vial
5 ml N1 vial
5 ml N10 vial
50 ml N1 vial
75 ml N1 vial
Rx
Rx
Rx
Rx
Rx
Rx
Rx
Rx
iv/intravesical
L01DB01
DOXORUBICIN EBEWE 2 MG/ML conc for sol for inf
25 ml N1 vial
5 ml N1 vial
Rx
Rx
iv
L01DB01
DOXORUBICIN TEVA 2 MG/ML conc for sol for inf
10 ml N1 (20 mg/10 ml) vial
100 ml N1 (200 mg/100 ml) vial
25 ml N1 (50 mg/25 ml) vial
5 ml N1 (10 mg/5 ml) vial
Rx
Rx
Rx
Rx
iv/intravesical
L01DB01
DOXORUBICIN-TEVA 10 MG powd for sol for inj
N1 vial
Rx
iv
L01DB01
DOXORUBICIN-TEVA 50 MG powd for sol for inj
N1 vial
Rx
iv
L01DB01
MYOCET LIPOSOMAL [MYOCET] 50 MG powd, disp & solv for conc for disp for inf
N1 (doksorubicino HCl+Myocet liposomos+b
N2 (doksorubicino HCl+Myocet liposomos+b
Rx
Rx
iv
L01DB01
RIBODOXO 2 MG/ML conc for sol for inf
25 ml N1 nenurodyta
5 ml N1 nenurodyta
Rx
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
A.D. MYCIN 50 MG/25 ML conc for sol for inf
N1 nenurodyta
Nominal
CAELYX PEGYLATED LIPOSOMAL [CAELYX] 2 MG/ML conc for sol for inf
10 ml N1 vial
10 ml N10 vial
25 ml N1 vial
25 ml N10 vial
EU/1/96/011/001
EU/1/96/011/002
EU/1/96/011/003
EU/1/96/011/004
CP
CP
CP
CP
21-06-1996
21-06-1996
21-06-1996
21-06-1996
CAELYX PEGYLATED LIPOSOMAL [CAELYX] 2 MG/ML conc for sol for inf
10 ml N1 vial
EU/1/96/011/001
CR-PD
22-07-2010
DOKSORUBICINA HIDROCHLORID 10 MG powd for sol for inf
N1 nenurodyta
Nominal
DOKSORUBICINAS MYLAN [DOKSORUBICINAS AGILA] 2 MG/ML powd for conc for sol for inf
10 mg N1 vial
50 mg N1 vial
LT/1/15/3737/005
LT/1/15/3737/006
DCP
DCP
16-06-2015
16-06-2015
DOKSORUBICINAS MYLAN [DOKSORUBICINAS AGILA] 2 MG/ML conc for sol for inf
10 ml N1 (20 mg /10 ml) vial
100 ml N1 (200 mg/100 ml) vial
25 ml N1 (50 mg/25 ml) vial
5 ml N1 (10 mg/5 ml) vial
LT/1/15/3737/002
LT/1/15/3737/004
LT/1/15/3737/003
LT/1/15/3737/001
DCP
DCP
DCP
DCP
16-06-2015
16-06-2015
16-06-2015
16-06-2015
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
10 ml N1 vial
100 ml N1 vial
25 ml N1 vial
5 ml N1 vial
50 ml N1 vial
LT/1/10/2139/004
LT/1/10/2139/003
LT/1/10/2139/002
LT/1/10/2139/001
LT/1/10/2139/005
DCP
DCP
DCP
DCP
DCP
13-08-2010
13-08-2010
13-08-2010
13-08-2010
13-08-2010
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
10 ml N1 vial
10 ml N10 vial
100 ml N1 vial
25 ml N1 vial
5 ml N1 vial
5 ml N10 vial
50 ml N1 vial
75 ml N1 vial
LT/1/12/2848/003
LT/1/12/2848/004
LT/1/12/2848/008
LT/1/12/2848/005
LT/1/12/2848/001
LT/1/12/2848/002
LT/1/12/2848/006
LT/1/12/2848/007
DCP
DCP
DCP
DCP
DCP
DCP
DCP
DCP
15-03-2012
15-03-2012
15-03-2012
15-03-2012
15-03-2012
15-03-2012
15-03-2012
15-03-2012
DOXORUBICIN EBEWE 2 MG/ML conc for sol for inf
25 ml N1 vial
5 ml N1 vial
LT/1/95/0631/002
LT/1/95/0631/001
NP
NP
04-10-1995
04-10-1995
DOXORUBICIN TEVA 2 MG/ML conc for sol for inf
10 ml N1 (20 mg/10 ml) vial
100 ml N1 (200 mg/100 ml) vial
25 ml N1 (50 mg/25 ml) vial
5 ml N1 (10 mg/5 ml) vial
LT/1/09/1812/002
LT/1/09/1812/004
LT/1/09/1812/003
LT/1/09/1812/001
DCP
DCP
DCP
DCP
23-12-2009
23-12-2009
23-12-2009
23-12-2009
DOXORUBICIN-TEVA 10 MG powd for sol for inj
N1 vial
LT/1/98/0616/001
NP
28-01-1998
DOXORUBICIN-TEVA 50 MG powd for sol for inj
N1 vial
LT/1/98/0616/002
NP
28-01-1998
MYOCET LIPOSOMAL [MYOCET] 50 MG powd, disp & solv for conc for disp for inf
N1 (doksorubicino HCl+Myocet liposomos+b
N2 (doksorubicino HCl+Myocet liposomos+b
EU/1/00/141/002
EU/1/00/141/001
CP
CP
29-03-2006
29-03-2006
RIBODOXO 2 MG/ML conc for sol for inf
25 ml N1 nenurodyta
5 ml N1 nenurodyta
Nominal
Nominal
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (14)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
DOXORUBICIN 2 MG/ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN ACTAVIS 2MG/ML (100MG/50ML) conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN ACTAVIS 2MG/ML (10MG/5ML) conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN ACTAVIS 2MG/ML (150MG/75ML) conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN ACTAVIS 2MG/ML (200MG/100ML) conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN ACTAVIS 2MG/ML (20MG/10ML) conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN ACTAVIS 2MG/ML (50MG/25ML) conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN MYLAN CONCENTRATE FOR SOLN FOR INF 2MG/ML (100ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN MYLAN CONCENTRATE FOR SOLN FOR INF 2MG/ML (10ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN MYLAN CONCENTRATE FOR SOLN FOR INF 2MG/ML (25ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN MYLAN CONCENTRATE FOR SOLN FOR INF 2MG/ML (5ML V conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN MYLAN PDR/CONC/SOLN FOR INFUS 2MG/ML (10MG VIAL) powd for conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN MYLAN PDR/CONC/SOLN FOR INFUS 2MG/ML (50MG VIAL) powd for conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN TEVA 2MG/ML conc for sol for inf
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
DOXORUBICIN 2 MG/ML conc for sol for inf
AA770/11301
22-10-2020
DOXORUBICIN ACTAVIS 2MG/ML (100MG/50ML) conc for sol for inf
MA628/09004
21-01-2013
DOXORUBICIN ACTAVIS 2MG/ML (10MG/5ML) conc for sol for inf
MA628/09001
21-01-2013
DOXORUBICIN ACTAVIS 2MG/ML (150MG/75ML) conc for sol for inf
MA628/09005
21-01-2013
DOXORUBICIN ACTAVIS 2MG/ML (200MG/100ML) conc for sol for inf
MA628/09006
21-01-2013
DOXORUBICIN ACTAVIS 2MG/ML (20MG/10ML) conc for sol for inf
MA628/09002
21-01-2013
DOXORUBICIN ACTAVIS 2MG/ML (50MG/25ML) conc for sol for inf
MA628/09003
21-01-2013
DOXORUBICIN MYLAN CONCENTRATE FOR SOLN FOR INF 2MG/ML (100ML conc for sol for inf
MA767/02204
18-02-2015
DOXORUBICIN MYLAN CONCENTRATE FOR SOLN FOR INF 2MG/ML (10ML conc for sol for inf
MA767/02202
18-02-2015
DOXORUBICIN MYLAN CONCENTRATE FOR SOLN FOR INF 2MG/ML (25ML conc for sol for inf
MA767/02203
18-02-2015
DOXORUBICIN MYLAN CONCENTRATE FOR SOLN FOR INF 2MG/ML (5ML V conc for sol for inf
MA767/02201
18-02-2015
DOXORUBICIN MYLAN PDR/CONC/SOLN FOR INFUS 2MG/ML (10MG VIAL) powd for conc for sol for inf
MA767/02205
18-02-2015
DOXORUBICIN MYLAN PDR/CONC/SOLN FOR INFUS 2MG/ML (50MG VIAL) powd for conc for sol for inf
MA767/02206
18-02-2015
DOXORUBICIN TEVA 2MG/ML conc for sol for inf
AA565/16702
03-09-2020
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Netherlands (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAELYX, 2 MG/ML concentraat voor oplossing voor intraveneuze infusie
-
Rx
-
L01DB01
DOXORUBICINE ACCORD 2 MG/ML conc for sol for inf
-
Rx
iv/intravesical
L01DB01
DOXORUBICINE HCL AUROBINDO 2 MG/ML conc for sol for inf
-
Rx
iv/intravesical
L01DB01
DOXORUBICINE HCL HIKMA 2 MG/ML conc for sol for inf
-
Rx
iv/intravesical
L01DB01
DOXORUBICINE HCL ZYTOSERVICE DüSSELDORF 2 MG/ML sol for inj
-
Rx
iv/intravesical
L01DB01
DOXORUBICINE HYDROCHLORIDE 2 MG/ML PCH conc for sol for inf
-
Rx
iv
L01DB01
MYOCET 50 MG, POEDER dispersie en oplosmiddel voor concentraat voor dispersie voor infusie
-
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAELYX, 2 MG/ML concentraat voor oplossing voor intraveneuze infusie
EU/1/96/011
-
21-06-1996
DOXORUBICINE ACCORD 2 MG/ML conc for sol for inf
RVG 103617
-
25-05-2011
DOXORUBICINE HCL AUROBINDO 2 MG/ML conc for sol for inf
RVG 109099
-
27-02-2012
DOXORUBICINE HCL HIKMA 2 MG/ML conc for sol for inf
RVG 113860
-
30-03-2015
DOXORUBICINE HCL ZYTOSERVICE DüSSELDORF 2 MG/ML sol for inj
RVG 33449
-
13-07-2006
DOXORUBICINE HYDROCHLORIDE 2 MG/ML PCH conc for sol for inf
RVG 102758
-
07-07-2010
MYOCET 50 MG, POEDER dispersie en oplosmiddel voor concentraat voor dispersie voor infusie
EU/1/00/141
-
13-07-2000
Product
Pack
SPC
PIL
Company
CAELYX, 2 MG/ML concentraat voor oplossing voor intraveneuze infusie
DOXORUBICINE ACCORD 2 MG/ML conc for sol for inf
DOXORUBICINE HCL AUROBINDO 2 MG/ML conc for sol for inf
DOXORUBICINE HCL HIKMA 2 MG/ML conc for sol for inf
DOXORUBICINE HCL ZYTOSERVICE DüSSELDORF 2 MG/ML sol for inj
DOXORUBICINE HYDROCHLORIDE 2 MG/ML PCH conc for sol for inf
MYOCET 50 MG, POEDER dispersie en oplosmiddel voor concentraat voor dispersie voor infusie
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIAMYCIN 2 MG/ML sol for inj
10
25
-
-
Rx
Rx
iv
L01DB01
ADRIAMYCIN PULV TIL 50 MG powd for sol for inj
1 x 50
-
Rx
iv
L01DB01
CAELYX PEGYLATED LIPOSOMAL KONS TIL 2 MG/ML conc for sol for inf
1 x 10
-
Rx
iv/intravesical
L01DB01
DOXORUBICIN ACCORD KONS TIL 2 MG/ML conc for sol for inf
10
100
25
5
-
-
-
-
Rx
Rx
Rx
Rx
iv/intravesical
L01DB01
DOXORUBICIN EBEWE 2 MG/ML sol for inj
25
-
Rx
iv
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIAMYCIN 2 MG/ML sol for inj
10
25
01-01-2001
01-01-2001
ADRIAMYCIN PULV TIL 50 MG powd for sol for inj
1 x 50
01-01-2001
CAELYX PEGYLATED LIPOSOMAL KONS TIL 2 MG/ML conc for sol for inf
1 x 10
18-11-2002
DOXORUBICIN ACCORD KONS TIL 2 MG/ML conc for sol for inf
10
100
25
5
15-02-2014
01-02-2013
15-02-2012
15-04-2014
DOXORUBICIN EBEWE 2 MG/ML sol for inj
25
01-11-2005
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (6)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIBLASTINA PFS 2 MG/ML sol for inj
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
-
-
-
Lz
Lz
Lz
-
L01DB01
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 25 ml
10 vial 10 ml
10 vial 25 ml
-
-
-
-
Rx
Rx
Rx
Rx
-
L01DB01
DOXORUBICIN MEDAC 2 MG/ML sol for inf
1 vial 10 ml
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 75 ml
-
-
-
-
-
Rx
Rx
Rx
Rx
Rx
-
L01DB01
DOXORUBICIN-EBEWE 2 MG/ML conc for sol for inf
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
-
-
-
-
Rx
Rx
Rx
Rx
-
L01DB01
DOXORUBICINUM ACCORD 2 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
-
-
-
-
-
Lz
Lz
Lz
Lz
Lz
-
L01DB01
MYOCET LIPOSOMAL 50 MG proszek, dyspersja i rozpuszczalnik do koncentratu do sporządzania dyspersji do infuzji
1 zestaw po 3 fiolki
2 zestawy po 3 fiolki
-
-

Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIBLASTINA PFS 2 MG/ML sol for inj
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
04710
04710
04710
NP
NP
NP
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 25 ml
10 vial 10 ml
10 vial 25 ml
CP
CP
CP
CP
DOXORUBICIN MEDAC 2 MG/ML sol for inf
1 vial 10 ml
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 75 ml
18042
18042
18042
18042
18042
MRP
MRP
MRP
MRP
MRP
DOXORUBICIN-EBEWE 2 MG/ML conc for sol for inf
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
04290
04290
04290
04290
NP
NP
NP
NP
DOXORUBICINUM ACCORD 2 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
17953
17953
17953
17953
17953
DCP
DCP
DCP
DCP
DCP
MYOCET LIPOSOMAL 50 MG proszek, dyspersja i rozpuszczalnik do koncentratu do sporządzania dyspersji do infuzji
1 zestaw po 3 fiolki
2 zestawy po 3 fiolki
CP
CP
Product
Pack
SPC
PIL
Company
ADRIBLASTINA PFS 2 MG/ML sol for inj
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 25 ml
10 vial 10 ml
10 vial 25 ml
DOXORUBICIN MEDAC 2 MG/ML sol for inf
1 vial 10 ml
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 75 ml
DOXORUBICIN-EBEWE 2 MG/ML conc for sol for inf
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
DOXORUBICINUM ACCORD 2 MG/ML conc for sol for inf
1 vial 10 ml
1 vial 100 ml
1 vial 25 ml
1 vial 5 ml
1 vial 50 ml
MYOCET LIPOSOMAL 50 MG proszek, dyspersja i rozpuszczalnik do koncentratu do sporządzania dyspersji do infuzji
1 zestaw po 3 fiolki
2 zestawy po 3 fiolki
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAELYX 2 MG/ML CONC. PT. SOL. PERF.
x 1 flacon din sticla x 10 ml
x 10 flacoane din sticla x 10 ml
-
-
S
S
-
L01DB01
DOXORUBICINA ACCORD 2 MG/ML CONC. PT. SOL. PERF.
1 flac. din sticla incolora a 10 ml conc
1 flac. din sticla incolora a 100 ml con
1 flac. din sticla incolora a 25 ml conc
1 flac. din sticla incolora a 5 ml conc.
1 flac. din sticla incolora a 50 ml conc
-
-
-
-
-
PR
PR
PR
PR
PR
-
L01DB01
MYOCET 50 MG PULB. + AMESTC. PT. CONC. PT.DISP.LIPOZOM.PT.PERF
x 2 seturi x 3 flac. (1 flac pulb. + 1 f
-
PR
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAELYX 2 MG/ML CONC. PT. SOL. PERF.
x 1 flacon din sticla x 10 ml
x 10 flacoane din sticla x 10 ml
-
-
DOXORUBICINA ACCORD 2 MG/ML CONC. PT. SOL. PERF.
1 flac. din sticla incolora a 10 ml conc
1 flac. din sticla incolora a 100 ml con
1 flac. din sticla incolora a 25 ml conc
1 flac. din sticla incolora a 5 ml conc.
1 flac. din sticla incolora a 50 ml conc
-
-
-
-
-
MYOCET 50 MG PULB. + AMESTC. PT. CONC. PT.DISP.LIPOZOM.PT.PERF
x 2 seturi x 3 flac. (1 flac pulb. + 1 f
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (20)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIBLASTINA 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
N
N
Rx
Rx
iv
L01DB01
ADRIBLASTINA RAPID DISSOLUTION inj
steklenička 10mg lyophila in ampula 5ml
steklenička 50 mg lyophila
-
-
Rx
Rx
parenteral
L01DB01
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
eno vial 10 ml conc
eno vial 25 ml conc
N
N
Rx
Rx
iv
L01DB01
DEBDOX 2 MG/ML powd for conc for sol for inf
1 vial praškom
-
Rx
iv
L01DB01
DOKSORUBICIN ACCORD 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
1 vial 50 ml conc
N
T
N
N
-
Rx
Rx
Rx
Rx
Rx
iv
L01DB01
DOKSORUBICIN AGILA SPECIALTIES 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
N
N
N
N
Rx
Rx
Rx
Rx
iv
L01DB01
DOKSORUBICIN AGILA SPECIALTIES 2 MG/ML ZA ZA RAZTOPINO ZA powd for conc for sol for inf
1 vial praškom
1 vial praškom
N
N
Rx
Rx
iv
L01DB01
DOKSORUBICIN SANDOZ 2 MG/ML conc for sol for inf
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
1 vial 50 ml conc
T
T
T
T
Rx
Rx
Rx
Rx
iv
L01DB01
DOKSORUBICIN TEVA 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
-
N
N
N
Rx
Rx
Rx
Rx
iv
L01DB01
DOXORUBICIN PLIVA 10 MG powd for sol for inj/inf
1 prebodno stekleničko praškom
10 prebodnimi stekleničkami praškom
-
-
Rx
Rx
parenteral
L01DB01
DOXORUBICIN PLIVA 50 MG powd for sol for inj/inf
1 prebodno stekleničko praškom
-
Rx
parenteral
L01DB01
DOXORUBICIN TEVA 2MG/ML sol for inj
1 vial 25 ml
-
-
L01DB01
DOXORUBIN 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
10 vial 25 ml sol
10 vial 5 ml sol
-
-
-
-
Rx
Rx
Rx
Rx
parenteral
L01DB01
DOXORUBIN 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
-
-

-
L01DB01
LIPODOX 2 MG/ML ZA PRIPRAVO INFUZIJE conc for sol for inf
1 vial 10 ml conc
-
-
L01DB01
LIPODOX 50 2 MG/ML ZA PRIPRAVO INFUZIJE conc for sol for inf
1 vial 25 ml conc
-
-
L01DB01
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
1 kompletom eno vial za vsako izmed treh
2 kompletoma eno vial za vsako izmed tre
-
N
Rx
Rx
iv
L01DB01
SINDROXOCIN 2 MG/ML powd for sol for inf
30 ml vial praškom
-
-
L01DB01
XORUCIN 10 MG powd for sol for inj
1 vial (volumen 8 ml) praškom
-
Rx
iv
L01DB01
XORUCIN 50 MG powd for sol for inj
1 vial (volumen 30 ml) praškom
1 vial (volumen 50 ml) praškom
-
N
Rx
Rx
iv
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIBLASTINA 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
103-108/2015-3
103-108/2015-3
NP
NP
30-12-2015
30-12-2015
30-12-2015
30-12-2015
30-06-2017
30-06-2017
ADRIBLASTINA RAPID DISSOLUTION inj
steklenička 10mg lyophila in ampula 5ml
steklenička 50 mg lyophila
-
-
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
eno vial 10 ml conc
eno vial 25 ml conc
EU/1/96/011/001
EU/1/96/011/003
CP
CP
23-04-2012
23-04-2012
DEBDOX 2 MG/ML powd for conc for sol for inf
1 vial praškom
103-117/2016-3
DCP
23-11-2016
23-11-2016
23-11-2016
DOKSORUBICIN ACCORD 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
1 vial 50 ml conc
1011-64/2014-10
1011-64/2014-10
1011-64/2014-10
1011-64/2014-10
1011-64/2014-10
DCP
DCP
DCP
DCP
DCP
18-06-2019
18-06-2019
18-06-2019
18-06-2019
18-06-2019
DOKSORUBICIN AGILA SPECIALTIES 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
1010-0345/2010-1
1010-0345/2010-1
1010-0345/2010-1
1010-0345/2010-1
DCP
DCP
DCP
DCP
27-10-2015
27-10-2015
27-10-2015
27-10-2015
27-10-2020
27-10-2020
27-10-2020
27-10-2020
DOKSORUBICIN AGILA SPECIALTIES 2 MG/ML ZA ZA RAZTOPINO ZA powd for conc for sol for inf
1 vial praškom
1 vial praškom
1010-0345/2010-1
1010-0345/2010-1
DCP
DCP
27-10-2015
27-10-2015
27-10-2020
27-10-2020
DOKSORUBICIN SANDOZ 2 MG/ML conc for sol for inf
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
1 vial 50 ml conc
103-58/2020-4
103-58/2020-4
103-58/2020-4
103-58/2020-4
NP
NP
NP
NP
12-10-2020
12-10-2020
12-10-2020
12-10-2020
DOKSORUBICIN TEVA 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
10123-451/2015-7
10123-451/2015-7
10123-451/2015-7
10123-451/2015-7
DCP
DCP
DCP
DCP
06-06-2016
06-06-2016
06-06-2016
06-06-2016
DOXORUBICIN PLIVA 10 MG powd for sol for inj/inf
1 prebodno stekleničko praškom
10 prebodnimi stekleničkami praškom
-
-
DOXORUBICIN PLIVA 50 MG powd for sol for inj/inf
1 prebodno stekleničko praškom
-
DOXORUBICIN TEVA 2MG/ML sol for inj
1 vial 25 ml
/
-
18-05-2012
18-05-2013
DOXORUBIN 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
10 vial 25 ml sol
10 vial 5 ml sol
-
-
-
-
DOXORUBIN 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
/
/
-
-
13-01-2010
13-01-2010
13-01-2011
13-01-2011
LIPODOX 2 MG/ML ZA PRIPRAVO INFUZIJE conc for sol for inf
1 vial 10 ml conc
/
-
29-06-2012
29-06-2013
LIPODOX 50 2 MG/ML ZA PRIPRAVO INFUZIJE conc for sol for inf
1 vial 25 ml conc
/
-
29-06-2012
29-06-2013
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
1 kompletom eno vial za vsako izmed treh
2 kompletoma eno vial za vsako izmed tre
EU/1/00/141/002
EU/1/00/141/001
CP
CP
23-04-2012
23-04-2012
SINDROXOCIN 2 MG/ML powd for sol for inf
30 ml vial praškom
/
-
08-08-2017
08-08-2018
XORUCIN 10 MG powd for sol for inj
1 vial (volumen 8 ml) praškom
1011-5/2014-11
DCP
23-11-2020
XORUCIN 50 MG powd for sol for inj
1 vial (volumen 30 ml) praškom
1 vial (volumen 50 ml) praškom
1011-5/2014-11
1011-5/2014-11
DCP
DCP
23-11-2020
23-11-2020
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
ADRIBLASTINA 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
ADRIBLASTINA RAPID DISSOLUTION inj
steklenička 10mg lyophila in ampula 5ml
steklenička 50 mg lyophila
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
eno vial 10 ml conc
eno vial 25 ml conc
318,34
795,4
DEBDOX 2 MG/ML powd for conc for sol for inf
1 vial praškom
DOKSORUBICIN ACCORD 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
1 vial 50 ml conc
153,78
43,72
DOKSORUBICIN AGILA SPECIALTIES 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
DOKSORUBICIN AGILA SPECIALTIES 2 MG/ML ZA ZA RAZTOPINO ZA powd for conc for sol for inf
1 vial praškom
1 vial praškom
DOKSORUBICIN SANDOZ 2 MG/ML conc for sol for inf
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
1 vial 50 ml conc
DOKSORUBICIN TEVA 2 MG/ML conc for sol for inf
1 vial 10 ml conc
1 vial 100 ml conc
1 vial 25 ml conc
1 vial 5 ml conc
43,72
DOXORUBICIN PLIVA 10 MG powd for sol for inj/inf
1 prebodno stekleničko praškom
10 prebodnimi stekleničkami praškom
DOXORUBICIN PLIVA 50 MG powd for sol for inj/inf
1 prebodno stekleničko praškom
DOXORUBICIN TEVA 2MG/ML sol for inj
1 vial 25 ml
DOXORUBIN 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
10 vial 25 ml sol
10 vial 5 ml sol
DOXORUBIN 2 MG/ML sol for inj
1 vial 25 ml sol
1 vial 5 ml sol
LIPODOX 2 MG/ML ZA PRIPRAVO INFUZIJE conc for sol for inf
1 vial 10 ml conc
LIPODOX 50 2 MG/ML ZA PRIPRAVO INFUZIJE conc for sol for inf
1 vial 25 ml conc
MYOCET LIPOSOMAL 50 MG powd, disp & solv for conc for disp for inf
1 kompletom eno vial za vsako izmed treh
2 kompletoma eno vial za vsako izmed tre
1685,61
SINDROXOCIN 2 MG/ML powd for sol for inf
30 ml vial praškom
XORUCIN 10 MG powd for sol for inj
1 vial (volumen 8 ml) praškom
XORUCIN 50 MG powd for sol for inj
1 vial (volumen 30 ml) praškom
1 vial (volumen 50 ml) praškom
68,14
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (12)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
1 vial of 10 ml
Y
Rx
iv
L01DB01
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML sol for inj
1 vial of 25 ml
-
Rx
iv
L01DB01
DOXORUBICINA ACCORD 2 MG /ML conc for sol for inf
1 via of 50 ml
1 vial of 100 ml
1 vial of 25 ml
1 vial of 5 ml
Y
Y
Y
Y
Rx
Rx
Rx
Rx
iv/intravesical
L01DB01
DOXORUBICINA AUROVITAS 2 MG/ML conc for sol for inf
1 vial of 100 ml
1 vial of 25 ml
1 vial of 5 ml
1 vial of 50 ml
Y
Y
-
Y
Rx
Rx
Rx
Rx
iv/intravesical
L01DB01
DOXORUBICINA SANDOZ 10 MG powd for conc for sol for inf
1 vial of 5 ml
-
Rx
iv/intravesical
L01DB01
DOXORUBICINA SANDOZ 50 MG conc for sol for inf
1 vial of 25 ml
-
Rx
iv/intravesical
L01DB01
DOXORUBICINA TEDEC 2 MG/ML sol for inj
1 vial of 25 ml
1 vial of 5 ml
Y
-
Rx
Rx
iv/intravesical
L01DB01
DOXORUBICINA TEDEC 50 MG INYECTABLE powd for conc for sol for inf
1 vial
50 vials
-
-
Rx
Rx
iv/intravesical
L01DB01
FARMIBLASTINA 10 MG powd & solv for sol for inf
1 vial + 1 amp of solv
50 vials + 50 amp of solv
-
-
Rx
Rx
iv/intravesical
L01DB01
FARMIBLASTINA 2 MG/ML conc for sol for inf
1 vial of 25 ml
1 vial of 5 ml
25 vials of 25 ml
50 vials of 5 ml
Y
Y
Y
Y
Rx
Rx
Rx
Rx
iv/intravesical
L01DB01
FARMIBLASTINA 50 MG powd for sol for inj
1 vial
25 vials
Y
Y
Rx
Rx
iv/intravesical
L01DB01
MYOCET LIPOSOMAL 50 MG POLVO, DISPERSION Y DISOLVENTE PARA powd for conc for disp for inf
2 kits (kit compuesto por 1 vial of 50 m
Y
Rx
iv
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
1 vial of 10 ml
96011001
01-07-1997
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML sol for inj
1 vial of 25 ml
96011003
17-01-2001
DOXORUBICINA ACCORD 2 MG /ML conc for sol for inf
1 via of 50 ml
1 vial of 100 ml
1 vial of 25 ml
1 vial of 5 ml
73266
73266
73266
73266
04-07-2011
04-07-2011
04-07-2011
04-07-2011
DOXORUBICINA AUROVITAS 2 MG/ML conc for sol for inf
1 vial of 100 ml
1 vial of 25 ml
1 vial of 5 ml
1 vial of 50 ml
75345
75345
75345
75345
20-04-2012
20-04-2012
20-04-2012
20-04-2012
DOXORUBICINA SANDOZ 10 MG powd for conc for sol for inf
1 vial of 5 ml
62177
01-09-1998
DOXORUBICINA SANDOZ 50 MG conc for sol for inf
1 vial of 25 ml
62178
01-09-1998
DOXORUBICINA TEDEC 2 MG/ML sol for inj
1 vial of 25 ml
1 vial of 5 ml
61085
61085
01-07-1996
01-07-1996
DOXORUBICINA TEDEC 50 MG INYECTABLE powd for conc for sol for inf
1 vial
50 vials
59772
59772
01-02-1993
01-02-1993
FARMIBLASTINA 10 MG powd & solv for sol for inf
1 vial + 1 amp of solv
50 vials + 50 amp of solv
51296
51296
01-06-1973
01-06-1973
FARMIBLASTINA 2 MG/ML conc for sol for inf
1 vial of 25 ml
1 vial of 5 ml
25 vials of 25 ml
50 vials of 5 ml
59739
59739
59739
59739
01-07-1993
01-07-1993
01-07-1993
01-07-1993
FARMIBLASTINA 50 MG powd for sol for inj
1 vial
25 vials
56172
56172
01-08-1983
01-08-1983
MYOCET LIPOSOMAL 50 MG POLVO, DISPERSION Y DISOLVENTE PARA powd for conc for disp for inf
2 kits (kit compuesto por 1 vial of 50 m
00141001
14-06-2001
Product
Pack
SPC
PIL
Company
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML conc for sol for inf
1 vial of 10 ml
CAELYX PEGYLATED LIPOSOMAL 2 MG/ML sol for inj
1 vial of 25 ml
DOXORUBICINA ACCORD 2 MG /ML conc for sol for inf
1 via of 50 ml
1 vial of 100 ml
1 vial of 25 ml
1 vial of 5 ml
DOXORUBICINA AUROVITAS 2 MG/ML conc for sol for inf
1 vial of 100 ml
1 vial of 25 ml
1 vial of 5 ml
1 vial of 50 ml
DOXORUBICINA SANDOZ 10 MG powd for conc for sol for inf
1 vial of 5 ml
DOXORUBICINA SANDOZ 50 MG conc for sol for inf
1 vial of 25 ml
DOXORUBICINA TEDEC 2 MG/ML sol for inj
1 vial of 25 ml
1 vial of 5 ml
DOXORUBICINA TEDEC 50 MG INYECTABLE powd for conc for sol for inf
1 vial
50 vials
FARMIBLASTINA 10 MG powd & solv for sol for inf
1 vial + 1 amp of solv
50 vials + 50 amp of solv
FARMIBLASTINA 2 MG/ML conc for sol for inf
1 vial of 25 ml
1 vial of 5 ml
25 vials of 25 ml
50 vials of 5 ml
FARMIBLASTINA 50 MG powd for sol for inj
1 vial
25 vials
MYOCET LIPOSOMAL 50 MG POLVO, DISPERSION Y DISOLVENTE PARA powd for conc for disp for inf
2 kits (kit compuesto por 1 vial of 50 m
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (12)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIAMYCIN 2 MG/ML sol for inj
Rx
-
L01DB01
CAELYX PEGYLATED LIPOSOMAL (FD CAELYX) 2 MG/ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN COPHARMA (FD DOXORUBICIN CARDINAL HEALTH) 2 MG/M conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN EBEWE (FD DOXORUBICIN PHARMALINK) 2 MG/ML sol for inj
Rx
-
L01DB01
DOXORUBICIN MYLAN (FD DOXORUBICIN AGILA) 2 MG/ML powd for conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN MYLAN (FD DOXORUBICIN AGILA) 2 MG/ML conc for sol for inf
Rx
-
L01DB01
DOXORUBICIN STADA (FD DOXORUBICIN PERIVITA) 2 MG/ML sol for inj
Rx
-
L01DB01
DOXORUBICIN TEVA (FD DOXORUBICIN) 2 MG/ML sol for inj
Rx
-
L01DB01
DOXORUBICIN TEVA 2 MG/ML powd for conc for sol for inf
Rx
-
L01DB01
MYOCET LIPOSOMAL (FD MYOCET) 50 MG powd, disp & solv for conc for disp for inf
Rx
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIAMYCIN 2 MG/ML sol for inj
Nationell decentral eller ömsesidig
16-09-1988
01-05-2013
CAELYX PEGYLATED LIPOSOMAL (FD CAELYX) 2 MG/ML conc for sol for inf
CP
21-06-1996
DOXORUBICIN ACCORD 2 MG/ML conc for sol for inf
Nationell decentral eller ömsesidig
18-06-2010
DOXORUBICIN ACTAVIS 2 MG/ML conc for sol for inf
Nationell decentral eller ömsesidig
09-12-2011
DOXORUBICIN COPHARMA (FD DOXORUBICIN CARDINAL HEALTH) 2 MG/M conc for sol for inf
Nationell decentral eller ömsesidig
04-12-2009
04-12-2014
DOXORUBICIN EBEWE (FD DOXORUBICIN PHARMALINK) 2 MG/ML sol for inj
Nationell decentral eller ömsesidig
23-04-1999
DOXORUBICIN MYLAN (FD DOXORUBICIN AGILA) 2 MG/ML powd for conc for sol for inf
Nationell decentral eller ömsesidig
09-01-2015
30-06-2016
DOXORUBICIN MYLAN (FD DOXORUBICIN AGILA) 2 MG/ML conc for sol for inf
Nationell decentral eller ömsesidig
09-01-2015
30-06-2016
DOXORUBICIN STADA (FD DOXORUBICIN PERIVITA) 2 MG/ML sol for inj
Nationell decentral eller ömsesidig
03-05-2002
30-04-2014
DOXORUBICIN TEVA (FD DOXORUBICIN) 2 MG/ML sol for inj
Nationell decentral eller ömsesidig
22-02-1991
DOXORUBICIN TEVA 2 MG/ML powd for conc for sol for inf
Nationell decentral eller ömsesidig
10-12-2010
10-12-2013
MYOCET LIPOSOMAL (FD MYOCET) 50 MG powd, disp & solv for conc for disp for inf
CP
13-07-2000
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (17)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ADRIBLASTIN RD 10 MG powd & solv for sol for inj
-
A
-
L01DB01
ADRIBLASTIN RD 50 MG Pulver zur Herstellung einer Injektionslösung
-
A
-
L01DB01
ADRIBLASTIN SOLUTION 10 MG/5 ML sol for inj
-
A
-
L01DB01
ADRIBLASTIN SOLUTION 20 MG/10 ML sol for inj
-
A
-
L01DB01
ADRIBLASTIN SOLUTION 50 MG/25 ML sol for inj
-
A
-
L01DB01
CAELYX conc for sol for inf
-
A
-
L01DB01
DOXORUBICIN PHARMINTRACO, 10 MG lyophil
-
A
-
L01DB01
DOXORUBICIN PHARMINTRACO, 20 MG lyophil
-
A
-
L01DB01
DOXORUBICIN PHARMINTRACO, 50 MG lyophil
-
A
-
L01DB01
DOXORUBICIN SANDOZ ECO 10 MG sol for inj
-
A
-
L01DB01
DOXORUBICIN SANDOZ ECO 100 MG sol for inj
-
A
-
L01DB01
DOXORUBICIN SANDOZ ECO 200 MG sol for inj
-
A
-
L01DB01
DOXORUBICIN SANDOZ ECO 50 MG sol for inj
-
A
-
L01DB01
DOXORUBICIN-TEVA 10 MG/5 ML sol for inj
-
A
-
L01DB01
DOXORUBICIN-TEVA 20 MG/10 ML sol for inj
-
A
-
L01DB01
DOXORUBICIN-TEVA 200 MG/100 ML sol for inj
-
A
-
L01DB01
DOXORUBICIN-TEVA 50 MG/25 ML sol for inj
-
A
-
L01DB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ADRIBLASTIN RD 10 MG powd & solv for sol for inj
50357 1
Hauptzulassung
27-10-1989
ADRIBLASTIN RD 50 MG Pulver zur Herstellung einer Injektionslösung
50357 3
Hauptzulassung
27-10-1989
ADRIBLASTIN SOLUTION 10 MG/5 ML sol for inj
50358 1
Hauptzulassung
24-06-1991
ADRIBLASTIN SOLUTION 20 MG/10 ML sol for inj
50358 2
Hauptzulassung
24-06-1991
ADRIBLASTIN SOLUTION 50 MG/25 ML sol for inj
50358 3
Hauptzulassung
24-06-1991
CAELYX conc for sol for inf
54273 1
Hauptzulassung
24-12-1997
DOXORUBICIN PHARMINTRACO, 10 MG lyophil
52910 1
Exportzulassung
27-02-1996
26-09-2021
DOXORUBICIN PHARMINTRACO, 20 MG lyophil
52910 2
Exportzulassung
27-02-1996
26-09-2021
DOXORUBICIN PHARMINTRACO, 50 MG lyophil
52910 3
Exportzulassung
27-02-1996
26-09-2021
DOXORUBICIN SANDOZ ECO 10 MG sol for inj
54828 1
Hauptzulassung
01-07-1999
27-01-2024
DOXORUBICIN SANDOZ ECO 100 MG sol for inj
54828 3
Hauptzulassung
01-07-1999
27-01-2024
DOXORUBICIN SANDOZ ECO 200 MG sol for inj
54828 4
Hauptzulassung
01-07-1999
27-01-2024
DOXORUBICIN SANDOZ ECO 50 MG sol for inj
54828 2
Hauptzulassung
01-07-1999
27-01-2024
DOXORUBICIN-TEVA 10 MG/5 ML sol for inj
59350 1
Hauptzulassung
02-12-2009
DOXORUBICIN-TEVA 20 MG/10 ML sol for inj
59350 2
Hauptzulassung
02-12-2009
DOXORUBICIN-TEVA 200 MG/100 ML sol for inj
59350 4
Hauptzulassung
02-12-2009
DOXORUBICIN-TEVA 50 MG/25 ML sol for inj
59350 3
Hauptzulassung
02-12-2009
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.